These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 33468262)

  • 1. Abdominal symptoms during Sjogren's syndrome: a pilot study.
    Parreau S; Jacques J; Dumonteil S; Palat S; Geyl S; Gondran G; Bezanahary H; Liozon E; Azaïs J; Colombie S; Jauberteau MO; Loustaud-Ratti V; Ly KH; Fauchais AL
    Adv Rheumatol; 2021 Jan; 61(1):5. PubMed ID: 33468262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Baseline disease activity influences subsequent achievement of patient acceptable symptom state in Sjögren's syndrome.
    Park EH; Ha YJ; Kang EH; Song YW; Scofield RH; Lee YJ
    Rheumatology (Oxford); 2021 Jun; 60(6):2714-2724. PubMed ID: 33188390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defining disease activity states and clinically meaningful improvement in primary Sjögren's syndrome with EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient-reported indexes (ESSPRI).
    Seror R; Bootsma H; Saraux A; Bowman SJ; Theander E; Brun JG; Baron G; Le Guern V; Devauchelle-Pensec V; Ramos-Casals M; Valim V; Dörner T; Tzioufas A; Gottenberg JE; Solans Laqué R; Mandl T; Hachulla E; Sivils KL; Ng WF; Fauchais AL; Bombardieri S; Priori R; Bartoloni E; Goeb V; Praprotnik S; Sumida T; Nishiyama S; Caporali R; Kruize AA; Vollenweider C; Ravaud P; Meiners P; Brito-Zerón P; Vitali C; Mariette X;
    Ann Rheum Dis; 2016 Feb; 75(2):382-9. PubMed ID: 25480887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient indexes (ESSPRI).
    Seror R; Theander E; Brun JG; Ramos-Casals M; Valim V; Dörner T; Bootsma H; Tzioufas A; Solans-Laqué R; Mandl T; Gottenberg JE; Hachulla E; Sivils KL; Ng WF; Fauchais AL; Bombardieri S; Valesini G; Bartoloni E; Saraux A; Tomsic M; Sumida T; Nishiyama S; Caporali R; Kruize AA; Vollenweider C; Ravaud P; Vitali C; Mariette X; Bowman SJ;
    Ann Rheum Dis; 2015 May; 74(5):859-66. PubMed ID: 24442883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abatacept treatment reduces disease activity in early primary Sjögren's syndrome (open-label proof of concept ASAP study).
    Meiners PM; Vissink A; Kroese FG; Spijkervet FK; Smitt-Kamminga NS; Abdulahad WH; Bulthuis-Kuiper J; Brouwer E; Arends S; Bootsma H
    Ann Rheum Dis; 2014 Jul; 73(7):1393-6. PubMed ID: 24473674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of sleep quality on clinical features of primary Sjögren's syndrome.
    Chung SW; Hur J; Ha YJ; Kang EH; Hyon JY; Lee HJ; Song YW; Lee YJ
    Korean J Intern Med; 2019 Sep; 34(5):1154-1164. PubMed ID: 29458245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multi-center, open-label, randomized study to explore efficacy and safety of baricitinib in active primary Sjogren's syndrome patients.
    Bai W; Yang F; Xu H; Wei W; Li H; Zhang L; Zhao Y; Shi X; Zhang Y; Zeng X; Leng X
    Trials; 2023 Feb; 24(1):112. PubMed ID: 36793118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and clinical impact of fibromyalgia in patients with primary Sjögren's syndrome.
    Choi BY; Oh HJ; Lee YJ; Song YW
    Clin Exp Rheumatol; 2016; 34(2 Suppl 96):S9-13. PubMed ID: 26315451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disease activity and damage in patients with primary Sjogren's syndrome: Prognostic value of salivary gland ultrasonography.
    Milic V; Colic J; Cirkovic A; Stanojlovic S; Damjanov N
    PLoS One; 2019; 14(12):e0226498. PubMed ID: 31891590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The EULAR Sjogren's syndrome patient reported index as an independent determinant of health-related quality of life in primary Sjogren's syndrome patients: in comparison with non-Sjogren's sicca patients.
    Cho HJ; Yoo JJ; Yun CY; Kang EH; Lee HJ; Hyon JY; Song YW; Lee YJ
    Rheumatology (Oxford); 2013 Dec; 52(12):2208-17. PubMed ID: 24023247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated levels of faecal calprotectin in primary Sjögren's syndrome is common and associated with concomitant organic gastrointestinal disease.
    Andréasson K; Ohlsson B; Mandl T
    Arthritis Res Ther; 2016 Jan; 18():9. PubMed ID: 26759247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe intestinal dysbiosis is prevalent in primary Sjögren's syndrome and is associated with systemic disease activity.
    Mandl T; Marsal J; Olsson P; Ohlsson B; Andréasson K
    Arthritis Res Ther; 2017 Oct; 19(1):237. PubMed ID: 29065905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral neuropathy and health-related quality of life in patients with primary Sjögren's syndrome: a preliminary report.
    Jaskólska M; Chylińska M; Masiak A; Nowicka-Sauer K; Siemiński M; Ziętkiewicz M; Czuszyńska Z; Zdrojewski Z
    Rheumatol Int; 2020 Aug; 40(8):1267-1274. PubMed ID: 32172462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. European League Against Rheumatism Sjögren's Syndrome Disease Activity Index and European League Against Rheumatism Sjögren's Syndrome Patient-Reported Index: a complete picture of primary Sjögren's syndrome patients.
    Seror R; Gottenberg JE; Devauchelle-Pensec V; Dubost JJ; Le Guern V; Hayem G; Fauchais AL; Goeb V; Hachulla E; Hatron PY; Larroche C; Morel J; Pedriger A; Puechal X; Rist S; Saraux A; Sene D; Sibilia J; Vittecoq O; Zarnitsky C; Labetoulle M; Ravaud P; Mariette X
    Arthritis Care Res (Hoboken); 2013 Aug; 65(8):1358-64. PubMed ID: 23436737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe Health-Related Quality of Life Impairment in Active Primary Sjögren's Syndrome and Patient-Reported Outcomes: Data From a Large Therapeutic Trial.
    Cornec D; Devauchelle-Pensec V; Mariette X; Jousse-Joulin S; Berthelot JM; Perdriger A; Puéchal X; Le Guern V; Sibilia J; Gottenberg JE; Chiche L; Hachulla E; Yves Hatron P; Goeb V; Hayem G; Morel J; Zarnitsky C; Dubost JJ; Saliou P; Pers JO; Seror R; Saraux A
    Arthritis Care Res (Hoboken); 2017 Apr; 69(4):528-535. PubMed ID: 27390310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pain, xerostomia, and younger age are major determinants of fatigue in Korean patients with primary Sjögren's syndrome: a cohort study.
    Koh JH; Kwok SK; Lee J; Son CN; Kim JM; Kim HO; Park SH; Sung YK; Choe JY; Lee SS; Park SH
    Scand J Rheumatol; 2017 Jan; 46(1):49-55. PubMed ID: 27098775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pain and fatigue are predictors of quality of life in primary Sjögren's syndrome.
    Dias LH; Miyamoto ST; Giovelli RA; de Magalhães CIM; Valim V
    Adv Rheumatol; 2021 May; 61(1):28. PubMed ID: 34051867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of primary Sjögren's syndrome on female sexual function.
    van Nimwegen JF; Arends S; van Zuiden GS; Vissink A; Kroese FG; Bootsma H
    Rheumatology (Oxford); 2015 Jul; 54(7):1286-93. PubMed ID: 25652072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy and mechanism for action of iguratimod in primary Sjögren's syndrome patients.
    Jiang W; Zhang L; Zhao Y; He X; Hu C; Liu Y
    Int Ophthalmol; 2020 Nov; 40(11):3059-3065. PubMed ID: 32607949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do the European League Against Rheumatism (EULAR) Sjögren's syndrome outcome measures correlate with impaired quality of life, fatigue, anxiety and depression in primary Sjögren's syndrome?
    Omma A; Tecer D; Kucuksahin O; Sandikci SC; Yildiz F; Erten S
    Arch Med Sci; 2018 Jun; 14(4):830-837. PubMed ID: 30002701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.